Kids & teens (for parents) · Michigan
Studies for children and teens in Michigan
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
53 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.
- Location
- Bloomfield Hills, MI + 46 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Bloomfield Hills, MI + 33 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Bloomfield Hills, MI + 26 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Ann Arbor, MI + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- Ann Arbor, MI + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
Neurocrine Switzerland GmbH
- Location
- Ann Arbor, MI + 10 other US sites
- Eligibility basics
- Ages 4 mo–3
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Flint, MI + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Detroit, MI + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Clarkston, MI + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb
- Location
- Detroit, MI + 26 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 1/Phase 2
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Ionis Pharmaceuticals, Inc.
- Location
- Ann Arbor, MI + 4 other US sites
- Eligibility basics
- Ages 2–12
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Ann Arbor, MI + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 3
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Takeda
- Location
- Detroit, MI + 2 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 4
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Bausch Health Americas, Inc.
- Location
- Clinton Township, MI + 13 other US sites
- Eligibility basics
- Ages 9–11
- RecruitingPhase 2
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Pfizer
- Location
- Royal Oak, MI + 11 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Waterford, MI + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Ann Arbor, MI + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Ann Arbor, MI + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Auburn Hills, MI + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingHealthy volunteers
Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids
Wayne State University
- Location
- Detroit, MI
- Eligibility basics
- Ages 14–17
- RecruitingHealthy volunteers
Network Connectivity and Temporal Processing in Adolescents Who Stutter
University of Michigan
- Location
- Ann Arbor, MI
- Eligibility basics
- Ages 9–13
- RecruitingHealthy volunteersPhase 2/Phase 3
Food-Body-Mind Intervention (16 Weeks)
Michigan State University
- Location
- Jackson, MI
- Eligibility basics
- Ages 3–5
- RecruitingHealthy volunteers
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
University of Michigan
- Location
- Ann Arbor, MI + 8 other US sites
- Eligibility basics
- Ages 0 mo–17